NVO Novo Nordisk Group Net Assets per Single Share

Graphic logo of novonordisk.com (NVO)

Novo Nordisk A/S (NVO) management has ensured autonomous business growth regardless of macroeconomic conditions. This chart of book value per share on GURU.Markets illustrates how GLP-1 patents enable the company to exercise pricing power, while the integration of digital services with medications ensures customer retention. The value of 7.67 shapes the current metric, confirming the growth of the holding's real net assets.

NVO (Novo Nordisk AS) Accounting Value of a Share history from 07/04/2022 to 10/31/2026

Analytical breakdowns for novonordisk.com (NVO)

- current quotes and average value forecast:
Price Chart Novo Nordisk Inc.|NVO - Average Forecast Price
- market capitalization data:
Market Value Novo Nordisk A/S|NVO - Full Business Value
- shareholders' equity book value data:
Book Value per Share Novo Nordisk|NVO - Accounting Value of Company|Market Capitalization to Book Value Ratio novonordisk.com|NVO - Company Total Assets
- debt and solvency information:
Debt to Equity Novo Nordisk A/S|NVO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Novo Nordisk|NVO - Company Total Debt|Debts to Book Capitalization Novo Nordisk A/S|NVO - Company Long-Term Debts|Company Current Liabilities Novo Nordisk|Quick Ratio novonordisk.com
- net income and valuation multiples indicators:
NVO - Final Profit
Initial company analysis:Novo Nordisk Inc. (NVO)
Mass-produced product of Novo Nordisk

For Novo Nordisk A/S (NVO), the book value reflects the financial foundation for expansion within the obesity drug segment. This metric is calculated as the ratio of equity to the number of shares, measuring the actual value of net assets. By analyzing the book value per share data on GURU.Markets, an investor can discern the business's actual margin of safety. Growth in this metric confirms the effectiveness of capital expenditures in R&D and production capacity. Stable capital minimizes risks during aggressive scaling.

Competitors of Novo Nordisk A/S (NVO)

LLY - Net Assets per Single Share|Net Asset Value per Share AbbVie Corp.|AstraZeneca PLC (AZN) - Net Assets per Single Share|Share Book Value NVS (novartis.com)|MRK (Merck) - Book Value per Share|AMGN: Accounting Value of a Share|Book Value per Share PFE|Book Value per Share Sanofi Group (SNY)|Net Assets per Single Share Bristol-Myers Squibb BMY|Accounting Value of a Share GSK|TAK - Net Assets per Single Share|tevapharm.com (TEVA) - Accounting Value per Share|RDY: Book Value per Share|Mylan (VTRS) - Book Value per Share|Accounting Value per Share ROIV|ZLAB: Accounting Value of a Share|Book Value per Share BHC|COSM (Cosmos Health, Inc.) - Accounting Value of a Share